(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33%.
Bionano Genomics's earnings in 2026 is -$30,112,000.On average, 4 Wall Street analysts forecast BNGO's earnings for 2026 to be -$32,960,882, with the lowest BNGO earnings forecast at -$34,135,958, and the highest BNGO earnings forecast at -$31,286,399. On average, 3 Wall Street analysts forecast BNGO's earnings for 2027 to be -$13,840,717, with the lowest BNGO earnings forecast at -$13,297,943, and the highest BNGO earnings forecast at -$14,247,797.
In 2028, BNGO is forecast to generate -$7,419,766 in earnings, with the lowest earnings forecast at -$7,128,794 and the highest earnings forecast at -$7,637,994.